Passeri M - Search Results

1

A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.

Agnusdei D, Crepaldi G, Isaia G, Mazzuoli G, Ortolani S, Passeri M, Bufalino L, Gennari C. Agnusdei D, et al. Among authors: passeri m. Calcif Tissue Int. 1997 Aug;61(2):142-7. doi: 10.1007/s002239900312. Calcif Tissue Int. 1997. PMID: 9236262 Clinical Trial.

2

Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

Mazzuoli GF, Passeri M, Gennari C, Minisola S, Antonelli R, Valtorta C, Palummeri E, Cervellin GF, Gonnelli S, Francini G. Mazzuoli GF, et al. Among authors: passeri m. Calcif Tissue Int. 1986 Jan;38(1):3-8. doi: 10.1007/BF02556587. Calcif Tissue Int. 1986. PMID: 3079649 Clinical Trial.

3

Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.

Adami S, Bufalino L, Cervetti R, Di Marco C, Di Munno O, Fantasia L, Isaia GC, Serni U, Vecchiet L, Passeri M. Adami S, et al. Among authors: passeri m. Osteoporos Int. 1997;7(2):119-25. doi: 10.1007/BF01623686. Osteoporos Int. 1997. PMID: 9166391 Clinical Trial.

4

Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.

Gennari C, Adami S, Agnusdei D, Bufalíno L, Cervetti R, Crepaldi G, Di Marco C, Di Munno O, Fantasia L, Isaia GC, Mazzuoli GF, Ortolani S, Passeri M, Serni U, Vecchiet L. Gennari C, et al. Among authors: passeri m. Calcif Tissue Int. 1997;61 Suppl 1:S19-22. doi: 10.1007/s002239900380. Calcif Tissue Int. 1997. PMID: 9263612 Clinical Trial.

5

Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.

Gennari C, Agnusdei D, Crepaldi G, Isaia G, Mazzuoli G, Ortolani S, Bufalino L, Passeri M. Gennari C, et al. Among authors: passeri m. Menopause. 1998 Spring;5(1):9-15. Menopause. 1998. PMID: 9689189 Clinical Trial.

6

The role of calcitriol in the treatment of osteoporosis.

Nuti R, Bonucci E, Brancaccio D, Gallagher JC, Gennari C, Mazzuoli G, Passeri M, Sambrook P. Nuti R, et al. Among authors: passeri m. Calcif Tissue Int. 2000 Mar;66(3):239-40. doi: 10.1007/pl00005840. Calcif Tissue Int. 2000. PMID: 10666502 Review. No abstract available.

7

Short-term treatment of Paget's disease of bone with ipriflavone.

Agnusdei D, Camporeale A, Gonnelli S, Gennari C, Baroni MC, Passeri M. Agnusdei D, et al. Among authors: passeri m. Bone Miner. 1992 Oct;19 Suppl 1:S35-42. doi: 10.1016/0169-6009(92)90864-a. Bone Miner. 1992. PMID: 1422319 Clinical Trial.

8

Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis.

Agnusdei D, Adami S, Cervetti R, Crepaldi G, Di Munno O, Fantasia L, Isaia GC, Letizia G, Ortolani S, Passeri M, et al. Agnusdei D, et al. Among authors: passeri m. Bone Miner. 1992 Oct;19 Suppl 1:S43-8. doi: 10.1016/0169-6009(92)90865-b. Bone Miner. 1992. PMID: 1422320 Clinical Trial.

9

Effect of ipriflavone on bone mass in elderly osteoporotic women.

Passeri M, Biondi M, Costi D, Bufalino L, Castiglione GN, Di Peppe C, Abate G. Passeri M, et al. Bone Miner. 1992 Oct;19 Suppl 1:S57-62. doi: 10.1016/0169-6009(92)90867-d. Bone Miner. 1992. PMID: 1422322 Clinical Trial.

10

Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.

Adami S, Passeri M, Ortolani S, Broggini M, Carratelli L, Caruso I, Gandolini G, Gnessi L, Laurenzi M, Lombardi A, et al. Adami S, et al. Among authors: passeri m. Bone. 1995 Oct;17(4):383-90. doi: 10.1016/s8756-3282(95)00262-6. Bone. 1995. PMID: 8573412 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters